ASLN

ASLAN Pharmaceuticals Limited

0.32 USD
-0.00 (-0.12%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ASLAN Pharmaceuticals Limited stock is down -28.62% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 71.43% of the previous 6 June’s closed higher than May.

About ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited is a clinical-stage immunology focused biopharmaceutical company. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications. ASLAN003 is a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions.